CIBC Private Wealth Group
CRDF icon

CIBC Private Wealth Group’s Cardiff Oncology CRDF Stock Holding History

CIBC Private Wealth Group’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,000
Closed -$6.18K – 3425
2025
Q3 		$6.18K Buy
+3,000
New +$8.29K ﹤0.01% 2516

Other funds holding CRDF

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

CIBC Private Wealth Group's CRDF Position: Q4 2025 in Review

CIBC Private Wealth Group sold out of Cardiff Oncology (CRDF) in Q4 2025, closing a stake of 3,000 shares — an estimated $6.18K sold.

CIBC Private Wealth Group first reported a position in CRDF in Q3 2025 and held it in 1 quarter. The position peaked at $6.18K in Q3 2025. 110 funds tracked by Wall St. Rank hold CRDF as of Q4 2025.

  • CIBC Private Wealth Group reported no remaining Cardiff Oncology position as of Q4 2025 after selling out during the quarter.
  • CIBC Private Wealth Group sold 3,000 Cardiff Oncology shares in Q4 2025, an estimated $6.18K.
  • CIBC Private Wealth Group first reported a position in Cardiff Oncology in Q3 2025 and held it in 1 quarter.
  • CIBC Private Wealth Group's Cardiff Oncology position peaked at $6.18K in Q3 2025.
  • 110 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.